The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat
Authors:
- P.H.A. MutsaersPMP.H.A. Mutsaers
- M. RuevekampMRM. Ruevekamp
- J.G. McVieJMJ.G. McVie
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 51 (2) , 109-117
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatmentCancer Chemotherapy and Pharmacology, 1990
- Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)European Journal of Cancer and Clinical Oncology, 1989
- Advances in platinum cancer chemotherapyCancer and Metastasis Reviews, 1988
- Aspects of cytotoxic drug penetration, with particular reference to anthracyclinesCancer Chemotherapy and Pharmacology, 1987
- Antitumor activity of l-OHP in miceCancer Letters, 1985
- Topographic PIXE analysis of platinum levels in kidney slices from CIS-platin treated patientsNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 1985
- Target preparation of biological specimens for SPIXE measurementsNuclear Instruments and Methods in Physics Research, 1982
- Brief Communication: A Model System for Studies of Colon Carcinogenesis: Tumor Induction by a Single Injection of Methylazoxymethanol Acetate 2JNCI: Journal of the National Cancer Institute, 1974
- New platinum complexes with anti-tumour activityChemico-Biological Interactions, 1972
- X-ray analysis: Elemental trace analysis at the 10−12 g levelNuclear Instruments and Methods, 1970